Genomic Testing Articles & Analysis
3 articles found
ESMO updated its recommendations for NGS in advanced cancers this year, urging broader use of NGS in additional cancer types and the inclusion of tumor-agnostic biomarkers. The ESMO Precision Medicine Working Group (PMWG) first published its recommendations for when to use next-generation sequencing (NGS) in routine practice for patients with metastatic cancers in 20201. At that time, based ...
Today, commercially available microarray-based tests enable more accurate cancer profiling based on genetic biomarkers like HER2, ER, and PR. ...
Weather variances—like temperature, humidity, and dryness outside—affected the genetic tests done inside the lab, leading to imperfect and inconsistent testing conditions. ...